TY - JOUR
T1 - Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells
AU - Posch, Wilfried
AU - Steger, Marion
AU - Knackmuss, Ulla
AU - Blatzer, Michael
AU - Baldauf, Hanna Mari
AU - Doppler, Wolfgang
AU - White, Tommy E.
AU - Hörtnagl, Paul
AU - Diaz-Griffero, Felipe
AU - Lass-Flörl, Cornelia
AU - Hackl, Hubert
AU - Moris, Arnaud
AU - Keppler, Oliver T.
AU - Wilflingseder, Doris
N1 - Publisher Copyright:
© 2015 Posch et al.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - DCs express intrinsic cellular defense mechanisms to specifically inhibit HIV-1 replication. Thus, DCs are productively infected only at very low levels with HIV-1, and this non-permissiveness of DCs is suggested to go along with viral evasion. We now illustrate that complement-opsonized HIV-1 (HIV-C) efficiently bypasses SAMHD1 restriction and productively infects DCs including BDCA-1 DCs. Efficient DC infection by HIV-C was also observed using single-cycle HIV-C, and correlated with a remarkable elevated SAMHD1 T592 phosphorylation but not SAMHD1 degradation. If SAMHD1 phosphorylation was blocked using a CDK2-inhibitor HIV-C-induced DC infection was also significantly abrogated. Additionally, we found a higher maturation and co-stimulatory potential, aberrant type I interferon expression and signaling as well as a stronger induction of cellular immune responses in HIV-C-treated DCs. Collectively, our data highlight a novel protective mechanism mediated by complement opsonization of HIV to effectively promote DC immune functions, which might be in the future exploited to tackle HIV infection.
AB - DCs express intrinsic cellular defense mechanisms to specifically inhibit HIV-1 replication. Thus, DCs are productively infected only at very low levels with HIV-1, and this non-permissiveness of DCs is suggested to go along with viral evasion. We now illustrate that complement-opsonized HIV-1 (HIV-C) efficiently bypasses SAMHD1 restriction and productively infects DCs including BDCA-1 DCs. Efficient DC infection by HIV-C was also observed using single-cycle HIV-C, and correlated with a remarkable elevated SAMHD1 T592 phosphorylation but not SAMHD1 degradation. If SAMHD1 phosphorylation was blocked using a CDK2-inhibitor HIV-C-induced DC infection was also significantly abrogated. Additionally, we found a higher maturation and co-stimulatory potential, aberrant type I interferon expression and signaling as well as a stronger induction of cellular immune responses in HIV-C-treated DCs. Collectively, our data highlight a novel protective mechanism mediated by complement opsonization of HIV to effectively promote DC immune functions, which might be in the future exploited to tackle HIV infection.
UR - http://www.scopus.com/inward/record.url?scp=84936763308&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84936763308&partnerID=8YFLogxK
U2 - 10.1371/journal.ppat.1005005
DO - 10.1371/journal.ppat.1005005
M3 - Article
C2 - 26121641
AN - SCOPUS:84936763308
SN - 1553-7366
VL - 11
JO - PLoS pathogens
JF - PLoS pathogens
IS - 6
M1 - e1005005
ER -